Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
Erratum: Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 30, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 25, 2026
Pediatric-inspired therapy and blinatumomab consolidation improve outcomes in young adults with Philadelphia-like acute lymphoblastic leukemia.
Journal: Haematologica
Published: June 24, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.
Journal: American journal of hematology
Published: May 29, 2026
Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: May 01, 2026
Experimental JAK inhibitors: the current, present, and future in graft-versus-host disease management?
Journal: Expert opinion on investigational drugs
Published: March 11, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: January 30, 2026
The Effect of Belumosudil on the Therapeutic Drug Levels of Tacrolimus and Sirolimus in Allogeneic Hematopoietic Transplantation.
Journal: Transplantation and cellular therapy
Published: January 30, 2026
Efficacy of Splenectomy for Hematologic Malignancies: A Retrospective Cohort Study.
Journal: Annals of surgery
Published: January 28, 2026
Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT.
Journal: Blood neoplasia
Published: December 19, 2025
Last Updated: 09/26/2026